The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.
about
Electronic audit and feedback intervention with action implementation toolbox to improve pain management in intensive care: protocol for a laboratory experiment and cluster randomised trialTreatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy?Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock.Pathogens and antimicrobial susceptibility profiles in critically ill patients with bloodstream infections: a descriptive study.Short-Course Adjunctive Gentamicin as Empirical Therapy in Patients With Severe Sepsis and Septic Shock: A Prospective Observational Cohort Study.High target attainment for β-lactam antibiotics in intensive care unit patients when actual minimum inhibitory concentrations are applied.Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model.Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling.Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study.Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance.Optimization and evaluation of piperacillin plus tobramycin combination dosage regimens against Pseudomonas aeruginosa for patients with altered pharmacokinetics via the hollow-fiber infection model and mechanism-based modeling.Optimization of a meropenem plus tobramycin combination dosage regimen against hypermutable and non-hypermutable Pseudomonas aeruginosa via mechanism-based modeling and the hollow-fiber infection model.Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations
P2860
Q33730359-A394DE23-4985-49DE-B93D-3688E5C533D7Q37146405-29DBB216-C35E-438A-A627-676BA984FB9AQ37389435-CAAB2834-6731-49B5-8531-726BD5CD2866Q37521007-47FFF931-4023-46ED-8E09-5A793876780BQ38432516-B2ECFA10-FBC3-4155-BE19-DF945CCC4647Q38798373-CA04D96A-9803-429A-BE2D-DF321D14A52EQ39936905-AAB48273-BCA4-44EE-A9BE-D7EC5CED2872Q40306198-340FF7BA-5491-4D45-ADF5-152F3B646ACBQ40657200-FAA06796-DCFE-406E-92E9-C9775D631ECBQ42654588-E1D89532-CCD3-459E-8B5C-7936569E7D13Q48329739-7222284A-6527-4B35-B7B5-E7B2B35370D8Q49792113-1340210E-FC0E-44F7-A6B5-1EF457C221AFQ50044377-4DAF437D-EEC2-4A44-96AC-0DEFA6F74211Q58699337-E0C9E79D-35C7-414E-9C48-BE26849EC876
P2860
The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.
@en
type
label
The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.
@en
prefLabel
The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.
@en
P2093
P2860
P50
P356
P1476
The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.
@en
P2093
Greg Barton
Jan De Waele
Jean Ralph Zahar
Jean-Francois Timsit
Working Group for Antimicrobia ...... ntensive Care Medicine (ESICM)
P2860
P304
P356
10.1093/JAC/DKV165
P407
P577
2015-07-13T00:00:00Z